Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493215-25-000013
Filing Date
2025-10-29
Accepted
2025-10-29 21:14:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 10373
2 SCHEDULE 1 ex-99-10302025_011009.htm EX-99.1 12684
  Complete submission text file 0001493215-25-000013.txt   25009
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A

Mailing Address 3020 CALLAN ROAD SAN DIEGO CA 92121
Business Address 3020 CALLAN ROAD SAN DIEGO CA 92121 858-401-7900
Avidity Biosciences, Inc. (Subject) CIK: 0001599901 (see all company filings)

EIN.: 461336960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-91534 | Film No.: 251431814
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)